Please see below to view the renal trials taking place within the Peninsula Cancer Network
SORCE:A phase III RCT comparing Sorafenib with placebo in patients with Resected primary renal Cell carcinoma at high or intermediate risk or relapse
TRANSORCE (sub-study of SORCE)-A study to collect blood and tissue samples from consenting patients who have been diagnosed with renal cell cancer.